GSK nears end of OTC bidding process

November 15, 2011 | By Tracy Staton
Email LinkedIn
Tools

GlaxoSmithKline ($GSK) is weighing final offers for the portfolio of over-the-counter products it has put on the block, sources tell Reuters. The two front-runners in the second round of bidding are Bain Capital and a partnership between Blackstone and Prestige Brands, the sources said. Report

Filed Under

, ,

Comments

Press Releases

Featured Jobs